Home / News / World News / Article / Pfizer jab produces less antibodies against Delta variant: Lancet study

Pfizer jab produces less antibodies against Delta variant: Lancet study

It also shows that levels of these antibodies that are able to recognise and fight the virus are lower with increasing age, and that levels decline over time

Listen to this article :
Tunisians working in the tourism industry receive a dose of the Pfizer-BioNTech Covid-19 coronavirus vaccine on Friday in Tunis. Pic/AFP

Tunisians working in the tourism industry receive a dose of the Pfizer-BioNTech Covid-19 coronavirus vaccine on Friday in Tunis. Pic/AFP

People fully vaccinated by the Pfizer-BioNTech vaccine are likely to have more than five times lower levels of neutralising antibodies against the Delta variant first identified in India compared to the original strain, according to research published in The Lancet journal.

The study also shows that levels of these antibodies that are able to recognise and fight the virus are lower with increasing age, and that levels decline over time, providing additional evidence in support of plans to deliver a booster dose to vulnerable people.

How do you like the new new mid-day.com experience? Share your feedback and help us improve.

Read Next Story
Hundreds show up around Hong Kong park despite ban

Trending Stories

Latest Photoscta-pos

Latest VideosView All

Latest Web StoriesView All

Mid-Day FastView All

Advertisement